Citation Impact
Citing Papers
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer
2006
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
2003
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1
2006 Standout
Sjögren's syndrome
2005 Standout
Aromatase Inhibitors in Breast Cancer
2003
The neural control of micturition
2008 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Adaptive Control Methods for the Dose Individualisation of Anticancer Agents
2000
An in vivo model of intratumoural aromatase using aromatase‐transfected MCF7 human breast cancer cells
1995
The Uroepithelial-associated sensory web
2007
Interstitial cystitis–like urinary symptoms among patients with Sjögren’s syndrome: a population-based study in Finland
2003
The skin microbiome
2011 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Use of aromatase inhibitors in breast carcinoma.
1999
Novel transdermal photodynamic therapy using ATX-S10·Na(II) induces apoptosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice
2005
Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women
2005
Analysis of anticancer drugs: A review
2011 Standout
Cholinergic innervation and function in the prostate gland
2002
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Behavioral syndromes: an ecological and evolutionary overview
2004 Standout
Drug discovery from medicinal plants
2005 Standout
PIEZO2 in sensory neurons and urothelial cells coordinates urination
2020 StandoutNatureNobel
Role of the Tumor Microenvironment in Mediating Response to Anti-angiogenic Therapy
2000
Dietary lignans: physiology and potential for cardiovascular disease risk reduction
2010 Standout
Behavioral Syndromes: An Integrative Overview
2004 Standout
Use of molecular techniques to study microbial diversity in the skin: Chronic wounds reevaluated
2001
Changing physician performance. A systematic review of the effect of continuing medical education strategies
1995 Standout
Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydrocortisone
2000
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Phytoestrogen Exposure Correlation with Plasma Estradiol in Postmenopausal Women in European Prospective Investigation of Cancer and Nutrition-Norfolk May Involve Diet-Gene Interactions
2005
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies
2011 Standout
Bacterial Biofilm and its Role in the Pathogenesis of Disease
2020 Standout
Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.
1998 Standout
Aromatase inhibitors as potential cancer chemopreventives.
1998
Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.
1999
Integrating animal temperament within ecology and evolution
2007 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Developmental Integration and the Evolution of Pleiotropy
1996
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
2006 Standout
Systems analysis of adverse drug events. ADE Prevention Study Group.
1995 Standout
AUGMENTED STRETCH ACTIVATED ADENOSINE TRIPHOSPHATE RELEASE FROM BLADDER UROEPITHELIAL CELLS IN PATIENTS WITH INTERSTITIAL CYSTITIS
2001
Photodynamic Therapy in Dentistry
2007 Standout
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment*
1997
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
Protocol-Based Computer Reminders, the Quality of Care and the Non-Perfectability of Man
1976 Standout
Use of a Computer to Detect and Respond to Clinical Events: Its Effect on Clinician Behavior
1976
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Morphological Integration and Developmental Modularity
2008 Standout
Minimizing Tuberculosis Risk to Hospital Personnel and Students Exposed to Unsuspected Disease
1975
Costs and Benefits of Health Information Technology
2006 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Therapeutic drug monitoring of cancer chemotherapy
2007
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Works of S. Jacobs being referenced
Diagnosis and treatment of 20 tuberculous patients who entered a community hospital.
1972
Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women
1989
POLYMERASE CHAIN REACTION AMPLIFICATION OF BACTERIAL 16S rRNA GENES IN INTERSTITIAL CYSTITIS AND CONTROL PATIENT BLADDER BIOPSIES
1998
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.
1995
The influence of CGS 16949A on peripheral aromatisation in breast cancer patients
1991
Autonomic control of acid phosphatase exocrine secretion by the rat prostate
1989
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer
1992
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients
1992
Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer
1992
The human testis: a novel locus for thyrotropin-releasing hormone (TRH) and TRH mRNA.
1992
CONCENTRATIONS OF SPECIFIC EPITHELIAL GROWTH FACTORS IN THE URINE OF INTERSTITIAL CYSTITIS PATIENTS AND CONTROLS
1997
Effects of Annular Cranial Vault Modification on the Cranial Base and Face
1994
Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer.
1994
Decreased sup 3 H-Thymidine Incorporation By Human Bladder Epithelial Cells Following Exposure To Urine From Interstitial Cystitis Patients
1996
Charcot's arthropathy of the shoulder following intraarticular corticosteroid injections.
1993
Urine Autoantibodies in Interstitial Cystitis
1997